Effectively unavailable from food — it's made from shellfish shells, not something you eat.
Watch glucosamine prices →Can you get it from food?
Glucosamine is manufactured from the chitin in crustacean shells. There is no ordinary food that delivers it in supplement quantities: you don't eat prawn shells, and cartilage-containing foods provide only small and highly variable amounts. So unlike most of this list, there's no food arithmetic to do — which, given what the higher-quality trials show, may not matter much either way.
| Food | To match the dose | |
|---|---|---|
| Shellfish shells (chitin) | Not a food | The commercial source material |
| Bone broth, cartilage | Small and highly variable | Nowhere near supplement doses |
Standard glucosamine is shellfish-derived, which matters for shellfish allergy and for vegetarians. Fermented corn-derived versions exist.
What the research actually shows
Almost all glucosamine research targets joint disease outcomes, which are restricted representations under Australian advertising rules — so we can't summarise those findings alongside a link to buy it. What we can report is the pattern in the evidence quality, because that's a statement about research methods rather than a health claim. Cochrane's review found pooled analyses modestly favoured glucosamine, but that restricted analyses of the most rigorously conducted trials found no significant benefit on standard pain or function scores. Considering only high-quality studies, outcomes were about the same on glucosamine as on placebo. A 2026 umbrella review and an individual-patient-data meta-analysis from the OA Trial Bank have since examined the same question, including whether any particular subgroup benefits.
On certainty: That pattern — effects shrinking as trial quality rises — is the single most useful thing to know here, and it's a comment on methodology rather than on the product. Note also that the Longevity Mix carries 750 mg against a typical trial dose of 1500 mg.
The studies referenced
-
Glucosamine for osteoarthritis
Pooled analyses modestly favoured glucosamine; restricted analyses of rigorously conducted trials found no significant benefit on standard pain or function scores. -
Glucosamine for knee osteoarthritis: an umbrella review
Synthesises the existing body of systematic reviews on the question. -
Subgroup analyses of the effectiveness of oral glucosamine for knee and hip osteoarthritis: a systematic review and individual patient data meta-analysis from the OA Trial Bank
Examined whether specific patient subgroups show benefit, using individual-level rather than study-level data.